Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors

NCT00104286 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Troxatyl™ (Cytotoxic Chemotherapeutic)

Sponsor

SGX Pharmaceuticals, Inc.